Evaluating vaccines for HIV using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
Funded at University of Louisiana at Lafayette · NIH-10577409 · Data updated 2026-11-12
This study is looking at new HIV vaccines using Rhesus macaques to see how well they work and how they can help prevent the virus, with the goal of finding effective options to protect people from AIDS.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2022 |
| Award (this year) | $1,856,713 |
| NIH project number | 75N93020D00008-P00002-759302000004-1 |
| Project ID | NIH-10577409 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive vaccines developed through these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccine trials may not benefit directly from this research.
What this research studies
This research focuses on the use of nonhuman primates, specifically Rhesus macaques, to evaluate potential HIV vaccines and prevention strategies. The Simian Vaccine Evaluation Units (SVEUs) will provide resources for thorough testing of these vaccines, assessing immune responses and efficacy in preventing viral infections. By maintaining a breeding colony and conducting preclinical studies, the program aims to identify effective vaccines that can generate strong immune responses against HIV. This research is crucial for advancing our understanding of AIDS prevention and developing effective vaccines.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly impacting public health.
How similar studies have gone: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach is both tested and valuable in the field.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.